Track the 셀레믹스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 셀레믹스 has recorded 20 insider filings. Market capitalisation: €170.7bn. The latest transaction was reported on 8 June 2026 (Other). Among the most active insiders: 박종갑. The full history is openly available.
20
Insider Decl.
0
Thresholds
€19m
7 ops.
Buy Volume
€6m
4 ops.
Sell Volume
32Σ signal
Buys €19m€6m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,932 of 25,451 companies
25.7
score / 100
Value
25
Quality
26
FCF yld-3.0%
Earn yld-3.2%
EV/EBITDA·
ROE-37%
Gross mgn50%
Net mgn-70%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.